$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Perioperative peroneal nerve injury has a low overall incidence rate, but it can cause significant functional impairment20. Therefore, the ASA and ASRA guidelines both emphasize the identification and prevention of variable-risk sources, including standardized positioning, avoiding local compression, and early nerve assessment1,2. The peroneal nerve is located superficially at the fibular head and crosses a fibrous tunnel, making it highly sensitive to traction and external forces, and a high-incidence site for lower limb mononeuropathy5. Postoperative peroneal nerve lesions following spinal anesthesia are relatively rare, and the literature suggests that they often need to be differentiated from central or radicular events6,7. In this case, the lumbar spine MRI did not reveal any central injuries such as spinal cord contusion or epidural space-occupying lesions, but only showed a punctate high signal on T2-weighted imaging in the left L5 nerve root (indicating mild inflammatory edema); high-resolution ultrasound showed intact continuity of the left lower limb peroneal nerve without swelling, ruling out focal compression or space-occupying lesions; electrophysiological studies showed slowed motor conduction velocity, relative conduction block, low amplitude of distal CMAP, decreased peroneal nerve sensory wave, and normal tibial nerve parameters at the fibular head segment. Finally, the cause of injury is considered to be a demyelinating conduction block in the fibular head segment of the common peroneal nerve, which is secondary to L5 nerve root injury. The underlying mechanism is considered to be anesthesia-related transient neurotoxicity or mechanical injury, rather than typical positional compression8,9.
The uniqueness of this patient lies in his long-term diabetes and post-renal transplantation status. Diabetic peripheral neuropathy (DPN) forms a vulnerable neural baseline state through microvascular impairment, oxidative stress, and decreased myelin repair capacity10. The long-term use of immunosuppressants after renal transplantation further weakens nerve protection and repair functions; along with perioperative anesthesia-related factors, this results in a superimposed effect. The patient experienced radiating pain and electric shock sensations in the left lower limb during the puncture, indicating that the L5 nerve root may have been slightly mechanically irritated by the puncture needle. We identify the immediate recognition of this paresthesia and the subsequent cessation of needle advancement as the single most critical procedural step determining diagnostic clarity and therapeutic success. Had the operator ignored this warning sign or continued injection, the mechanical irritation could have progressed to severe axonal loss. The 0.75% ropivacaine used, although a low-toxicity local anesthetic, may exert a toxic effect on the perineurium of DPN patients (in whom perineurial permeability is increased). This model of a vulnerable neural baseline combined with perioperative stress explains the phenomenon of mononeuropathy in the absence of imaging findings of typical compression and is consistent with the findings of negative ultrasound results but positive EMG and MRI results.
In terms of diagnosis, for postoperative foot drop following spinal anesthesia, the assessment pathway of "rule out central, then clarify peripheral" should be followed: lumbar spine MRI should be prioritized to exclude spinal cord, nerve root, and epidural lesions6,7; high-resolution ultrasound should be used to quickly screen for anatomical abnormalities of the peroneal nerve (such as rupture, space-occupying lesions)14,15,16; electrophysiological studies can distinguish between conduction block and axonal degeneration14,15,16,17,18. Our structured diagnostic algorithm, which prioritized early multimodal assessment (MRI <48h, EMG days 7–14), illustrates the potential advantages over traditional "wait-and-see" strategies or isolated clinical observation. While conventional approaches often delay advanced imaging until conservative management fails—risking missed windows for reversible compression—our method rapidly distinguished between axonal degeneration and reversible conduction block in this case, thereby avoiding unnecessary interventions and accelerating targeted rehabilitation. This case suggests that early multimodal assessment may be beneficial for similar high-risk patients.
Decision-making is increasingly guided by a function-preserving, graded strategy distilled from evidence on compressive, neoplastic, and traumatic peripheral neuropathies: when features indicate predominant demyelinating block and imaging reveals no mass or scar tether, standardized conservative care and rehabilitation are prioritized; if no reinnervation trajectory is evident on serial strength testing and follow-up electrodiagnostic studies (EDX)/high-resolution ultrasound (HRUS) within 3–6 months, if progressive atrophy or refractory pain emerges, or if ultrasonography/MRI shows compressive change, evaluation for precise decompression/neurolysis is warranted. To assist clinicians in managing similar complex cases, we propose specific troubleshooting guidance: (1) For ambiguous diagnostic findings: If MRI is negative for compression but motor deficits persist beyond 48 h, do not assume functional recovery is imminent; immediately proceed to electrodiagnostic studies to differentiate between conduction block (favorable prognosis) and axonal degeneration (poor prognosis). (2) For delayed recovery: In diabetic patients, if no clinical improvement (e.g., return of muscle strength) is observed by 6 weeks, repeat EMG/NCS is mandatory to assess for reinnervation signs; absence of reinnervation potentials at this stage should prompt a re-evaluation for occult compressive lesions or consideration of surgical consultation. For nerve-sheath tumors, traumatic neuromas, or clear axonal discontinuity, a pathway of lesion-directed surgery with microsurgical reconstruction (including autograft as indicated) and staged rehabilitation is applied21,22. Contemporary series and reviews provide practical thresholds for reassessment timing, procedure selection, and functional follow-up, which informed our “6–8 weeks recheck → 3–6 months surgical review” milestones in this case21,22,23,24,25,26,27. In patients with diabetic foot, adherence to IWGDF off-loading principles can proceed in parallel with neural rehabilitation to improve tissue perfusion and reduce the risk of recurrence, supporting overall functional recovery28.
This study has several limitations regarding methodology and generalizability. First, as a single-case retrospective report, our findings are subject to selection bias and limited statistical power, restricting broad generalizability to all diabetic populations. Second, the retrospective data collection inherently restricted our ability to detail the precise granular mechanics of the anesthesia technique. Third, the use of a 1.5T MRI may lack the sensitivity of higher-field scanners (3.0T) for detecting subtle neural changes, potentially leading to false-negative findings on axial imaging. Finally, we could not definitively separate mechanical trauma from potential local anesthetic neurotoxicity, though the clinical presentation favors a mechanical etiology exacerbated by DPN.
Finally, it is important to emphasize the insights at the case level: For patients with underlying diseases such as diabetic peripheral neuropathy (DPN), baseline neurological function should be evaluated preoperatively; during anesthesia, priority should be given to selecting safe interspaces, using fine-needle puncture, and paying attention to patient feedback to avoid the accumulation of high-concentration local anesthetics and mechanical injury. For foot drop after spinal anesthesia in the context of diabetic foot, the inherent perception that it is caused by positional compression should be challenged, and MRI, HRUS, and EDX should be combined to distinguish between peripheral and central injuries. After confirming nerve injury, early implementation of nerve protection, rehabilitation, and metabolic management optimization can usually result in significant functional recovery within 3 months. For patients with stagnant recovery and evidence suggesting axonal degeneration or compression, the time window for surgical decompression and re-evaluation should be seized. Clinically, attention should be paid to the whole-process prevention and control of such rare complications, and precise assessment and intervention should be adopted to improve patient prognosis1,14,15,16,17,18,26. Future research and clinical applications should focus on two key directions: First, prospective multicenter studies are needed to define the optimal diagnostic timing window and cost-effectiveness of early MRI/EMG protocols specifically for high-risk diabetic populations undergoing neuraxial anesthesia. Second, clinical trials should investigate perioperative neuroprotective strategies (e.g., specific antioxidant regimens or optimized glycemic control protocols) to raise the threshold of nerve vulnerability in patients with pre-existing DPN, potentially preventing such iatrogenic injuries.